Pregnant or recently pregnant and something feels wrong? Know the urgent warning signs. In an emergency call 911.

Evidence review Research indexed

Comparison of different agents and doses of anti-vascular endothelial growth factors (aflibercept, bevacizumab, conbercept, ranibizumab) versus laser for retinopathy of prematurity: A network meta-analysis

Ortiz-Seller A, Martorell P, Barranco H, Pascual-Camps I, Morcillo E, Ortiz JL · Survey of ophthalmology · 2024-07-01

Read the original source

This entry is research indexed. We have confirmed the source details below and link to the original. Plain-language and professional summaries appear here only after a qualified clinician has reviewed them.

Source details

AuthorsOrtiz-Seller A, Martorell P, Barranco H, Pascual-Camps I, Morcillo E, Ortiz JL
Journal or publisherSurvey of ophthalmology
Published2024-07-01
DOI10.1016/j.survophthal.2024.02.005
PMID38432359
Document typeSystematic review or meta-analysis
Full textSee the PubMed record for publisher links
LicensingLinked only. Not reproduced.
Status notesInitial import 2026-11-11: metadata from PubMed, approved for the index as Research indexed (no summary).
Added to libraryNovember 11, 2026
Details last verifiedNovember 11, 2026

Questions to bring to your doctor

  • Does this guidance or study apply to my situation? Why or why not?
  • Has anything newer replaced it?
  • How does it change what you recommend for us?

Research describes groups of people and cannot predict the outcome for one pregnancy or one child. Report a problem with this entry